These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15607996)

  • 1. A comparison of health utility measures for the evaluation of multiple sclerosis treatments.
    Fisk JD; Brown MG; Sketris IS; Metz LM; Murray TJ; Stadnyk KJ
    J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):58-63. PubMed ID: 15607996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of health state in patients with tinnitus: a comparison of the EQ-5D and HUI mark III.
    Maes IH; Joore MA; Cima RF; Vlaeyen JW; Anteunis LJ
    Ear Hear; 2011; 32(4):428-35. PubMed ID: 21221004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the psychometric properties of generic utility measures in multiple sclerosis.
    Kuspinar A; Mayo NE
    Pharmacoeconomics; 2014 Aug; 32(8):759-73. PubMed ID: 24846760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S; Hockley C
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in cochlear implantees: comparing utility values obtained through the Medical Outcome Study Short-Form Survey-6D and the Health Utility Index Mark 3.
    Arnoldner C; Lin VY; Bresler R; Kaider A; Kuthubutheen J; Shipp D; Chen JM
    Laryngoscope; 2014 Nov; 124(11):2586-90. PubMed ID: 24536018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of utility measures for women with urge, stress, and mixed urinary incontinence.
    Harvie HS; Shea JA; Andy UU; Propert K; Schwartz JS; Arya LA
    Am J Obstet Gynecol; 2014 Jan; 210(1):85.e1-6. PubMed ID: 24055585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reliability and validity of the Disabilities of Arm, Shoulder, and Hand, EuroQol-5D, Health Utilities Index, and Short Form-6D outcome instruments in patients with proximal humeral fractures.
    Slobogean GP; Noonan VK; O'Brien PJ
    J Shoulder Elbow Surg; 2010 Apr; 19(3):342-8. PubMed ID: 20189839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosis.
    Prosser LA; Kuntz KM; Bar-Or A; Weinstein MC
    Value Health; 2004; 7(5):554-68. PubMed ID: 15367251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?
    Kuspinar A; Mayo NE
    Health Qual Life Outcomes; 2013 Apr; 11():71. PubMed ID: 23618072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.
    Gaujoux-Viala C; Rat AC; Guillemin F; Flipo RM; Fardellone P; Bourgeois P; Fautrel B
    J Rheumatol; 2011 Aug; 38(8):1576-84. PubMed ID: 21532054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the measurement properties and estimation of minimal important differences of the EQ-5D and SF-6D utility measures in patients with systemic sclerosis.
    Kwakkenbos L; Fransen J; Vonk MC; Becker ES; Jeurissen M; van den Hoogen FH; van den Ende CH
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):50-6. PubMed ID: 23910610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis: a head-to-head comparison.
    Oostenbrink R; A Moll HA; Essink-Bot ML
    J Clin Epidemiol; 2002 Aug; 55(8):791-9. PubMed ID: 12384194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative ability of quality of life measures in multiple sclerosis.
    Fiest KM; Greenfield J; Metz LM; Patten SB; Jetté N; Marrie RA
    Health Qual Life Outcomes; 2017 Dec; 15(1):246. PubMed ID: 29268750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis.
    Lillegraven S; Kristiansen IS; Kvien TK
    Ann Rheum Dis; 2010 Oct; 69(10):1762-7. PubMed ID: 20448285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the validity of two indirect utility instruments as measures of postoperative recovery.
    Lee L; Mata J; Augustin BR; Carli F; Morin N; Latimer E; Feldman LS
    J Surg Res; 2014 Jul; 190(1):79-86. PubMed ID: 24629417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health Utilities for Multiple Sclerosis.
    Hawton A; Green C
    Value Health; 2016 Jun; 19(4):460-8. PubMed ID: 27325338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using HAQ-DI to estimate HUI-3 and EQ-5D utility values for patients with rheumatoid arthritis in Spain.
    Carreño A; Fernández I; Badia X; Varela C; Roset M
    Value Health; 2011 Jan; 14(1):192-200. PubMed ID: 21211502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.
    Xie F; Li SC; Luo N; Lo NN; Yeo SJ; Yang KY; Fong KY; Thumboo J
    Arthritis Rheum; 2007 Aug; 57(6):1043-9. PubMed ID: 17665466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.